News Trends, News Analysis, News Archive.



Sanofi ends development of Clostridium difficile vaccine

healthNews reuters.com

(Reuters) - Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection, after an early look at late-stage trial results indicated a low probability for success. [Source]

Related Articles

Dengue Fever nytimes.com

Drug Company Under Fire After Revealing Dengue Vaccine May Harm Some

A promising vaccine for dengue fever is in limbo after the Philippines suspended its use amid widespread public anger and fears about its safety.

healthNews reuters.com

Sleep problems tied to female infertility

(Reuters Health) - Women with sleep disorders other than sleep apnea may be more than three times as likely to experience infertility as their counterparts who don’t have trouble sleeping, a recent study suggests.

healthNews reuters.com

Judge blocks Trump administration rules on contraceptive coverage

(Reuters) - A U.S. judge on Friday blocked President Donald Trump's administration from moving forward with new rules that undermined an Obamacare requirement for employers to provide health insurance that covers women's birth control.

companyNews reuters.com

BRIEF-Merit Medical Entered Into Third Amendment To Second Amended & Restated Credit Agreement & Incremental Increase Agreement

* MERIT MEDICAL SYSTEMS - ON DEC 13, MERIT ENTERED INTO THIRD AMENDMENT TO SECOND AMENDED & RESTATED CREDIT AGREEMENT & INCREMENTAL INCREASE AGREEMENT

healthNews reuters.com

Executive function declines long-term after 'transient' brain attacks

(Reuters Health) - People who have so-called transient neurological attacks, including brief mini-strokes, may develop cognitive problems that linger for months, a recent study suggests.

healthNews reuters.com

U.S. judge blocks Trump administration birth control rules

(Reuters) - A U.S. judge on Friday blocked President Donald Trump's administration from moving forward with new rules that undermined an Obamacare requirement for employers to provide health insurance that covers women's birth control.

healthNews reuters.com

Few California pharmacists prescribing birth control

(Reuters Health) - A California law allowing pharmacists to prescribe birth control sought to make it easier for women to obtain contraception, but few drug stores provide the service, a new study finds.

healthNews reuters.com

Ebola victims sue Sierra Leone government over mismanaged funds

FREETOWN (Reuters) - Two Ebola survivors in Sierra Leone filed a lawsuit in a regional court on Friday, accusing the government of mismanaging funds during an epidemic that killed more than 3,000 people in the West African nation.

healthNews reuters.com

Phone-based therapy sessions may help dementia caregivers cope

(Reuters Health) - Talk therapy that teaches emotional regulation and coping skills can help people caring for a loved-one with dementia improve their own physical and mental health, German researchers say.

healthNews reuters.com

Tobacco industry trumps as India court cancels stringent health labeling rules

NEW DELHI (Reuters) - An Indian court on Friday quashed federal rules that mandated stringent graphic health warnings on tobacco products, lawyers involved in the case said, in a decision seen as a major victory for the tobacco industry and a setback for health advocates.

healthNews reuters.com

India state court cancels 2014 federal rule on stringent tobacco pack warnings

NEW DELHI (Reuters) - An Indian court on Friday quashed federal rules that mandated stringent graphic health warnings on tobacco products, lawyers involved in the case said, in a decision seen as a major victory for the tobacco industry and a setback for health advocates.

healthNews reuters.com

Finland lets stores sell stronger drinks, health chiefs complain

HELSINKI (Reuters) - Finnish lawmakers narrowly voted on Friday to let grocery stores sell stronger alcoholic drinks, after months of public debate pitting supporters of drinker's rights against health campaigners.

healthNews reuters.com

Novo Nordisk wins EU panel's backing for key diabetes drug

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, its biggest growth prospect, when a European Medicines Agency (EMA) experts' panel issued a positive recommendation on Friday.

healthNews reuters.com

FDA allows Alnylam to restart hemophilia treatment trials

(Reuters) - The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a rare bleeding disorder, the company said on Friday.

healthNews reuters.com

Aclaris's drug to treat common skin growth gets FDA nod

(Reuters) - The U.S. Food and Drug Administration approved Aclaris Therapeutics Inc's topical drug to treat a common kind of skin growth called seborrheic keratoses, the company said on Friday.

healthNews reuters.com

Siemens buys Fast Track Diagnostics to boost molecular offering

FRANKFURT (Reuters) - Siemens said it has agreed to buy Luxembourg-based Fast Track Diagnostics to boost its molecular-testing offering, one of the areas it is keen to expand as it prepares to float its healthcare unit, Healthineers.

healthNews reuters.com

EU drugs agency says move to new HQ may take longer

LONDON (Reuters) - The European drugs agency said on Friday its new headquarters in Amsterdam may not be ready by the time it has to leave London due to Brexit because the building will not be completed.

healthNews reuters.com

Chinese tourists raid Danish supermarkets for infant milk powder

COPENHAGEN (Reuters) - Following a string of food safety scandals, Chinese tourists visiting Copenhagen have this year stocked up on Danish-made organic infant milk formula, prompting some supermarkets to limit the number of cans each customer can buy.

healthNews reuters.com

Thailand battles drug-resistant malaria strains that imperil global campaign

BO RAI, Thailand (Reuters) - Once a smuggling stop for Cambodia's Khmer Rouge guerrillas, Thailand's border town of Bo Rai finds itself on the frontline of a new battle against drug-resistant strains of malaria that could frustrate global attempts to stamp out the disease.

healthNews reuters.com

Cannabis ingredient holds promise as antipsychotic medicine

LONDON (Reuters) - An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said on Friday.

companyNews reuters.com

BRIEF-Aker BP invests NOK 15.5 bln in development of 3 fields off Norway

* ‍AKER BP ASA (AKER BP) HAS SUBMITTED PLANS FOR DEVELOPMENT AND OPERATIONS (PDOS) FOR VALHALL FLANK WEST, ÆRFUGL (FORMERLY SNADD) AND SKOGUL (FORMERLY STORKLAKKEN) FIELDS TO NORWEGIAN MINISTRY OF PETROLEUM AND ENERGY​

companyNews reuters.com

Brazil's Petrobras receives $3 billion in China Development Bank loan

SAO PAULO, Dec 14 (Reuters) - Brazil's state-controlled oil company Petroleo Brasileiro SA on Thursday received $3 billion under a $5 billion loan from China Development Bank, the company said in a securities filing.

healthNews reuters.com

Families of dementia patients see positive effect of social robot seal

(Reuters Health) - Paro, a robotic baby harp seal, seems to improve dementia patients’ mood and increase opportunities for communication with family members, according to a small study.

healthNews reuters.com

Merck's Keytruda fails pivotal gastric cancer trial

(Reuters) - Merck & Co Inc said on Thursday a key late-stage trial testing Keytruda failed to meet its main goal of extending the lives of patients with a type of gastric cancer.

healthNews reuters.com

Childhood obesity climbing with media use, European doctors warn

(Reuters Health) - Children’s waistlines have been expanding in lock step with the amount of time they spend with televisions, computers, smartphones and tablets, European doctors say.

healthNews reuters.com

Social media may help chronically ill connect to doctors, fellow patients

(Reuters Health) - Social media groups that bring together patients, family, friends and healthcare providers can improve patients’ outlook and reduce their anxiety and depression, a recent U.S. study suggests.

healthNews reuters.com

U.S. less generous than European nations with development assistance

(Reuters Health) - The U.S. contributes more than any other nation in development assistance for health to low- and middle-income countries, but its generosity falls short when compared in terms of size and wealth, a new study found.

healthNews reuters.com

Perrigo lines up bid for Merck's consumer health unit: sources

LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.

healthNews reuters.com

Transgender women may get small breasts with hormones

(Reuters Health) - Transgender women who take sex hormones to feminize their bodies may not experience as much breast development as they expect, a new European study suggests.

cnn.com

Trump's FCC repeals Obama-era net neutrality regulations intended to keep the web open and fair

The FCC will vote on whether to repeal net neutrality comes amid mounting protests from tech companies, consumer advocacy groups and even some Republicans in Congress.

healthNews reuters.com

Germany's Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulators' concerns about side effects having frustrated its ambitions almost seven years ago.

healthNews reuters.com

Brain cells develop more mutations as we age

(Reuters Health) - Brain cells - neurons - develop gene mutations over the course of a lifetime, contributing to normal aging and potentially presenting a target for treatments that stave off dementia and other types of cognitive decline, researchers say.

topNews reuters.com

Arms supplied by U.S., Saudi ended up with Islamic State, researchers say

BAGHDAD (Reuters) - Arms provided by the United States and Saudi Arabia to Syrian opposition groups frequently ended up in the hands of Islamic State, an arms monitoring group that analyzed weapons found on the battlefield said on Thursday.

healthNews reuters.com

With no deal on children's health plan, U.S. states scramble for Plan B

NEW YORK/WASHINGTON (Reuters) - For Nancy Minoui of Portland, Oregon, and Crystal Lett of Dublin, Ohio, Congress' failure to fund the Children's Health Insurance Program is not some distant tale of political wrangling.

healthNews reuters.com

Former Philippine President defends controversial dengue program

MANILA (Reuters) - Former Philippine President Benigno Aquino defended on Thursday his decision to implement a controversial immunization program using a new dengue vaccine in 2016, saying it was justified with millions of people at risk of being infected by the virus.

healthNews reuters.com

Treating bumps and humps: Dubai opens $10 million camel hospital

DUBAI (Reuters) - Pristine operating theaters and state-of-the-art medical equipment are featured in a new Dubai hospital that opened last week - exclusively for camels.

healthNews reuters.com

Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval

(Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, the company said on Wednesday.

healthNews reuters.com

Seasonal flu kills more globally than previously thought -U.S. study

CHICAGO (Reuters) - As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.

healthNews reuters.com

Ohio passes law barring abortion over Down syndrome diagnosis

CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.

healthNews reuters.com

Head and neck cancer survivors have long-lasting cognitive problems

(Reuters Health) - Patients who survive head and neck cancer may be more likely to experience declines in cognitive function than people who don’t have these tumors, a recent study suggests.

healthNews reuters.com

Fears of Israeli job cuts at Teva sparks call for general strike

TEL AVIV (Reuters) - Reports that Teva Pharmaceutical Industries is planning a restructuring involving mass layoffs in Israel sparked calls on Wednesday for a half-day general strike to be held in protest.

healthNews reuters.com

Shift work linked to burnout in sleep-deprived nurses

(Reuters Health) - Shift-work nurses who have sleep problems are more likely to experience career burnout that has the potential to compromise their job performance, a small Italian study suggests.

healthNews reuters.com

Music therapy may help ease depression

(Reuters Health) - Traditional depression treatments like psychotherapy or medication might work better for some patients when doctors add a dose of music therapy, a research review suggests.

healthNews reuters.com

Medtronic settles states' probe into Infuse marketing for $12 million

BOSTON (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

healthNews reuters.com

Irish parliament committee backs referendum on abortion up to 12 weeks

DUBLIN (Reuters) - An Irish parliamentary committee on Wednesday recommended that an abortion referendum due next year should offer the choice of allowing terminations with no restrictions up to 12 weeks into a pregnancy, a more liberal position than some had anticipated.

healthNews reuters.com

Revance will wait to seek backing for Botox-rival

(Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.

healthNews reuters.com

Obamacare sign-ups rise but overall enrollment set to fall

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.

healthNews reuters.com

Diabetes and obesity both tied to higher risk of cancer

(Reuters Health) - Many cancer cases worldwide may happen at least in part because people are overweight or have diabetes, a new report suggests.

healthNews reuters.com

Obamacare sign-ups rise to 1 million as pace picks up before deadline

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance next year surpassed the 1 million mark in the second-to-last week of enrollment on the federally-run HealthCare.gov website, picking up the pace ahead of the Dec. 15 deadline.

healthNews reuters.com

Obamacare sign-ups gain steam as 2018 deadline nears

NEW YORK (Reuters) - More than 1.07 million consumers selected 2018 Obamacare individual insurance plans on the HealthCare.gov website during the week ended Dec. 9, the U.S. government reported on Wednesday, indicating a pick up in the pace of enrollment as the Dec. 15 deadline nears.

healthNews reuters.com

Doner kebabs survive EU lawmaker vote on additives

STRASBOURG (Reuters) - Doner kebab vendors across Europe won a victory in the European Parliament on Wednesday when European Union lawmakers failed to outlaw additives regularly used to preserve taste and moisture.

healthNews reuters.com

Israel's Teva to cut jobs in restructuring on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include laying off more than half its Israeli workforce, the Calcalist financial news website said.

healthNews reuters.com

Half of world's people can't get basic health services: WHO

LONDON (Reuters) - At least half the world's population is unable to access essential health services and many others are forced into extreme poverty by having to pay for healthcare they cannot afford, the World Health Organization said on Wednesday.

healthNews reuters.com

Aurora Cannabis wins rights for licensing talks with CannaRoyalty

(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.

healthNews reuters.com

Philippines' Duterte says dengue campaign carried out in 'good faith'

MANILA (Reuters) - President Rodrigo Duterte believes the previous Philippine government acted in good faith in launching an immunization drive that used a new dengue vaccine on hundreds of thousands of children, he said on Wednesday.

healthNews reuters.com

France's Sanofi pins hopes on new drugs after setbacks

PARIS (Reuters) - French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth.

companyNews reuters.com

UPDATE 2-France's Sanofi pins hopes on new drugs after setbacks

* CEO says company on track to sell European generics unit (Adds details, shares)

healthNews reuters.com

Sanofi sees nine regulatory submissions over next 18 months

PARIS (Reuters) - Sanofi said on Wednesday it expected to file nine regulatory submissions for new drugs over the next 18 months and that its pipeline of new products would support long-term growth.

healthNews reuters.com

Teva Pharm to unveil restructuring plan on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include layoffs, the Calcalist financial news website said on Wednesday.

technologyNews reuters.com

Toyota, Panasonic consider joint development of EV batteries

TOKYO (Reuters) - Toyota Motor Corp and Panasonic Corp said on Wednesday they are considering jointly developing batteries for electric vehicles (EVs), a partnership that could help Panasonic extend its market lead in automotive lithium-ion batteries.

companyNews reuters.com

UPDATE 1-Toyota, Panasonic consider joint development of EV batteries

* Panasonic sees batteries as key to doubling auto biz revenue (Adds analyst comment, Toyota EV background, Panasonic battery background)

companyNews reuters.com

RPT-Toyota and Panasonic eye joint development of new EV batteries

TOKYO, Dec 13 (Reuters) - Japan's Panasonic Corp and Toyota Motor Corp said on Wednesday they will consider jointly developing batteries for electric vehicles.

companyNews reuters.com

BRIEF-Regeneron And Sanofi Announce Positive Topline Pivotal Results For Pd-1 Antibody Cemiplimab In Advanced Cutaneous Squamous Cell Carcinoma

* REGENERON AND SANOFI ANNOUNCE POSITIVE TOPLINE PIVOTAL RESULTS FOR PD-1 ANTIBODY CEMIPLIMAB IN ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA

healthNews reuters.com

Did Sanofi, WHO ignore warning signals on dengue vaccine?

CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease.

companyNews reuters.com

INSIGHT-Did Sanofi, WHO ignore warning signals on dengue vaccine?

* Vaccine can make risk of severe disease higher in some cases

healthNews reuters.com

U.S. judge questions Trump administration on birth control rules

OAKLAND, Calif. (Reuters) - A U.S. judge questioned on Tuesday whether the federal government properly formulated new rules that undermine an Obamacare requirement for employers to provide insurance that covers women's birth control.

healthNews reuters.com

Republicans propose to delay, pause Obamacare taxes

WASHINGTON (Reuters) - U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama's healthcare law, including a tax on medical devices and the so-called "Cadillac" tax on generous health insurance plans.

healthNews reuters.com

Many young U.S. men at high risk for HIV do not take anti-HIV pill

(Reuters Health) - Less than 4 percent of young adult men-who-have-sex-with-men in the U.S. – a population at significant risk of contracting the human immunodeficiency virus (HIV) – reported ever using the pill that protects them from the virus, in a recently published study.

healthNews reuters.com

Older women should not take hormones to prevent chronic diseases

(Reuters Health) - Postmenopausal women should not use hormone therapy to prevent chronic medical conditions, because the risk of significant side effects outweighs the unclear evidence of a benefit, according to a government-backed panel of experts.

healthNews reuters.com

Hearing loss may be a risk factor for dementia

(Reuters Health) - Older adults who develop hearing loss may more likely to experience dementia and cognitive decline than their counterparts without hearing problems, a research review suggests.

cnn.com

Sen. Gillibrand: It was intended to silence me. It won't

Sen. Kirsten Gillibrand (D-NY) responds to President Trump's tweet saying the senator "would do anything" for campaign money.

healthNews reuters.com

Motorcycle passengers have higher head injury risks

Reuters Health - Motorcycle passengers are less likely than drivers to wear helmets, and they are more likely to suffer traumatic brain injuries in crashes, a U.S. study suggests.

healthNews reuters.com

'Heat-not-burn' tobacco may be safer but still a risk: UK panel

LONDON (Reuters) - A new wave of "heat-not-burn" tobacco products are probably safer than traditional cigarettes but the devices still produce a number of potentially harmful compounds, some of which are carcinogenic, a British panel of experts said on Tuesday.

healthNews reuters.com

EU health and food safety experts warn of stubborn salmonella

LONDON (Reuters) - The number of salmonella food poisoning cases in the European Union has risen by 3 percent since 2014 in a "worrying" reversal of a decade-long declining trend, EU health and food safety officials said on Tuesday.

companyNews reuters.com

BRIEF-Hillenbrand Enters Second Amended Credit Agreement Among Co

* ON DEC 8, ENTERED SECOND AMENDED CREDIT AGREEMENT AMONG CO, WITH ITS SUBSIDIARY BORROWERS AND SUBSIDIARY GUARANTORS- SEC FILING

businessNews reuters.com

Sanofi investors hungry for drug progress and deal news

PARIS (Reuters) - Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its vaccines arm and looks set for another gloomy year in diabetes, investors told Reuters.

healthNews reuters.com

Cholera resurges in Zambian capital Lusaka, WHO says

GENEVA (Reuters) - Cholera has killed 15 people and made 547 sick in Zambia's capital Lusaka and the rising caseload is expected to grow further as the rainy season starts, according to the World Health Organization.

healthNews reuters.com

NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

(Reuters) - New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

healthNews reuters.com

Air pollution fine particles linked to poor sperm quality

(Reuters Health) - Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan.

healthNews reuters.com

Retirement linked to longer, better sleep

(Reuters Health) – As work worries abate, sleep difficulties may also diminish when workers make the transition to retirement, according to a recent study from Finland.

healthNews reuters.com

Amgen's Kyprolis improves overall survival in blood cancer patients

(Reuters) - Amgen Inc said on Monday new data from a late-stage trial testing Kyprolis in combination with two other drugs showed improved overall survival rate in patients with blood cancer.

healthNews reuters.com

Promising responses seen with Agios leukemia drug in study

(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.

healthNews reuters.com

Breast reconstruction after cancer less common at cash-strapped hospitals

(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.

healthNews reuters.com

Commuters often exposed to damaging noise levels

(Reuters Health) - Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.

healthNews reuters.com

Kids continue to die in window-blind accidents, despite safety warnings

(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.

healthNews reuters.com

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog

(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.

companyNews reuters.com

FDA clears Sanofi's follow-on diabetes biologic of Lilly's Humalog

Dec 11 (Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.

healthNews reuters.com

Austria to drop impending smoking ban, bucking Western trend

VIENNA (Reuters) - While much of the West has barred smoking in restaurants and bars, Austria's impending ban is set to be stubbed out.

healthNews reuters.com

Opioid painkiller prescriptions may run in families

Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.

businessNews reuters.com

WTO losing focus, must rethink development: U.S. trade chief

BUENOS AIRES (Reuters) - U.S. President Donald Trump's trade chief said on Monday that the World Trade Organization is losing its focus on trade negotiations in favor of litigation and needed to rethink how it defines developing economies.

healthNews reuters.com

'Ground-breaking' new drug gives hope in Huntington's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

businessNews reuters.com

Lighthizer says WTO losing focus, must rethink development

BUENOS AIRES (Reuters) - U.S. President Donald Trump's trade chief said on Monday that the World Trade Organization is losing its focus on trade negotiations in favor of litigation and needed to rethink how it defines developing economies.

healthNews reuters.com

'Ground-breaking' new drug gives hope on Huntingdon's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Kimberly Blackwell To Become Vice President Of Early Phase Development And Immuno-Oncology At Lilly Oncology

* KIMBERLY BLACKWELL, M.D., TO BECOME VICE PRESIDENT OF EARLY PHASE DEVELOPMENT AND IMMUNO-ONCOLOGY AT LILLY ONCOLOGY Source text for Eikon: Further company coverage:

healthNews reuters.com

Indonesia races to contain diphtheria outbreak ahead of 2018 Asian Games

JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capital’s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.

healthNews reuters.com

GSK's new pharma head on lookout for cancer deals to boost pipeline

LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

companyNews reuters.com

HSBC announces end to suspended sentence for Mexican cartel case

LONDON, Dec 11 (Reuters) - HSBC on Monday said its deferred prosecution agreement with the U.S. Department of Justice has expired, marking an end to the threat of further punishment for lapses in its anti-money laundering controls.

healthNews reuters.com

Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday

healthNews reuters.com

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.

healthNews reuters.com

Hospital operators in merger talks to form U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.

healthNews reuters.com

Hospital operators in merger talks to create U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.

healthNews reuters.com

Exclusive: Philippines defied experts' advice in pursuing dengue immunization program

MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.

healthNews reuters.com

France orders international recall of Lactalis baby formula

PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.

healthNews reuters.com

Gilead's new drug keeps 56 percent of lymphoma trial patients alive

(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

healthNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival: study

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

companyNews reuters.com

Pilatus jet development far exceeded planned costs - NZZ interview

ZURICH, Dec 9 (Reuters) - Swiss plane maker Pilatus's development costs of "well over 500 million Swiss francs" ($504 million) far exceeded the original budget for the company's first business jet, Chairman Oscar Schwenk told the Neue Zuercher Zeitung in an article published on Saturday.

companyNews reuters.com

BRIEF-‍MTY Files Restated Financial Statements For Year Ended Nov 30, 2016​

* ‍MTY FILES RESTATED FINANCIAL STATEMENTS FOR YEAR ENDED NOVEMBER 30, 2016​

healthNews reuters.com

U.S. House committee 'may reconsider' WHO cancer agency funds

LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.

healthNews reuters.com

Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

healthNews reuters.com

Lilly's Cyramza meets main goal in gastric cancer study

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

healthNews reuters.com

Depression in late teens linked to high school drop out

(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.

companyNews reuters.com

BRIEF-DCP Midstream Says, Co And Unit Entered Into Second Amended And Restated Credit Agreement

* DCP MIDSTREAM LP SAYS ON DEC 6, 2017, CO AND UNIT ENTERED INTO SECOND AMENDED AND RESTATED CREDIT AGREEMENT - SEC FILING

healthNews reuters.com

Kids who get moving may also get better grades

(Reuters Health) - Students who get extra physical activity may pay more attention in school and do better in subjects like reading and math, a research review suggests.

healthNews reuters.com

Acupressure app may help ease menstrual cramp pain

(Reuters Health) - Women with intense menstrual cramp pain may get more relief from smartphone app-guided acupressure than with typical medical treatments like painkillers, a recent study suggests.

healthNews reuters.com

Credibility, recipes, references help food blogs improve eating habits

(Reuters Health) - Consumers like healthy eating blogs written by nutritionists who seem credible and who interact with their readers, a small study in Canada suggests.

companyNews reuters.com

BRIEF-Tucows, Units, Enter Interim Amendment To First Amended And Restated Credit Agreement

* SAYS ON DEC 5, CO, UNITS, ENTERED INTERIM AMENDMENT TO FIRST AMENDED AND RESTATED CREDIT AGREEMENT

healthNews reuters.com

Uganda says it has contained an outbreak of Marburg hemorrhagic fever

KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.

healthNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in late stage study

(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

healthNews reuters.com

Top Russian pork producer Miratorg reports ASF outbreak

MOSCOW (Reuters) - Russia's largest pork producer Miratorg on Friday reported an outbreak of African Swine Fever (ASF) at one of its sites in the Belgorod region in central Russia.

companyNews reuters.com

BRIEF-Impax Receives Tentative fda Approval Of Generic Coreg CR (Carvedilol Phosphate) Extended-Release Capsules

* IMPAX RECEIVES TENTATIVE FDA APPROVAL OF GENERIC COREG CR® (CARVEDILOL PHOSPHATE) EXTENDED-RELEASE CAPSULES

healthNews reuters.com

Venezuela's chronic shortages give rise to 'medical flea markets'

SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.

healthNews reuters.com

Russia's meat firm Miratorg reports ASF outbreak at 1 site in Russia

MOSCOW (Reuters) - Russian privately-owned meat producer Miratorg said on Friday there was an outbreak of African Swine Fever (ASF) at one of its sites in Russia's Belgorod region.

companyNews reuters.com

BRIEF-Hess Corp Says Co,Certain Units Amended & Restated Existing 5-Year Credit Agreement Dated As Of Jan 21, 2015

* HESS CORP - ON DEC 1 CO,CERTAIN UNITS AMENDED & RESTATED EXISTING 5-YEAR CREDIT AGREEMENT DATED AS OF JANUARY 21, 2015 - SEC FILING

healthNews reuters.com

Philippines to seek refund of $59 million from Sanofi amid vaccine risk

MANILA (Reuters) - The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.

healthNews reuters.com

Roche study finds cancer 'Velcro' that halts T-cell attack

ZURICH (Reuters) - Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy drugs as well as a possible means of turning the tables to incite a T-cell attack.

healthNews reuters.com

U.S. Department of Justice investigating fetal tissue transfers

(Reuters) - The U.S. Department of Justice asked on Thursday for documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood, according to a letter seen by Reuters.

healthNews reuters.com

U.S. Department of Justice seeks documents on fetal tissue transfers

(Reuters) - The U.S. Department of Justice sent a letter on Thursday, seen by Reuters, seeking documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood.

healthNews reuters.com

Antibiotics sales for use in U.S. farm animals dropped in 2016: FDA

CHICAGO (Reuters) - The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday.

cnn.com

Analysis: WH says the election ended debate on Trump's treatment of women. Not exactly.

On Thursday afternoon, White House press secretary Sarah Sanders was asked about Al Franken's description of President Donald Trump as "a man who has bragged on tape about his history of sexual assault."

healthNews reuters.com

Childhood cancer survivors have more blood pressure problems

(Reuters Health) - More than one in 12 adult survivors of childhood cancers may have undiagnosed high blood pressure, a U.S. study suggests.

healthNews reuters.com

Faulty positioning in rugby tackles boosts injury risk

(Reuters Health) - Head, neck and shoulder injuries during rugby tackles are more common when the tackler’s head is incorrectly positioned in relation to the ball carrier, a small study has found.

healthNews reuters.com

Gum infections tied to increased risk of stomach cancer precursor

(Reuters Health) - Gum infections may increase people’s risk for sores in the digestive tract that can lead to stomach cancer, a small study suggests.

businessNews reuters.com

Uber's license suspended in British city of Sheffield

LONDON (Reuters) - Uber's license to operate in the northern English city of Sheffield was suspended last Friday after it failed to respond to requests about the management of its taxi app, the local authority said.

healthNews reuters.com

Open windows and doors can improve sleep quality

(Reuters Health) - Leaving a bedroom door or window open may help people sleep better, a study from the Netherlands suggests.

companyNews reuters.com

UPDATE 1-Uber's licence suspended in British city of Sheffield

LONDON, Dec 7 (Reuters) - Uber's licence to operate in the northern English city of Sheffield was suspended last Friday after it failed to respond to requests about the management of its taxi app, the local authority said.

domesticNews reuters.com

Indiana officer suspended for 'white male privilege' remark to learn fate

(Reuters) - A female Indiana police officer suspended after calling out a fellow officer for "white male privilege" during a transgender awareness training session may learn her job status on Thursday.

healthNews reuters.com

Sage shares surge as depression drug succeeds in mid-stage trial

(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.

healthNews reuters.com

South African egg prices seen rising 20 percent after avian flu outbreak

JOHANNESBURG (Reuters) - Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.

healthNews reuters.com

More than 2,000 drugs now in cancer immunotherapy race

LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.

healthNews reuters.com

Sage shares surge as depression drug succeeds mid-stage trial

(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.

healthNews reuters.com

Sage's depression drug succeeds in mid-stage study, shares soar

(Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.

healthNews reuters.com

Indonesia fights 'extraordinary' diphtheria outbreak that has killed 32

JAKARTA (Reuters) - Indonesian health authorities will launch an immunization drive next week to contain a sharp rise in cases of diphtheria, which has killed at least 32 people, including many children, in the world's fourth most populous country this year.

healthNews reuters.com

Knee surgery outcomes linked with education level

(Reuters Health) - Patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, a recent study suggests.

healthNews reuters.com

Study confirms higher breast cancer risk with hormone-based contraception

(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded.

healthNews reuters.com

U.S. healthcare spending growth slowed in 2016

(Reuters) - Growth in healthcare spending in the United States slowed in 2016 following two years of expansion under the Affordable Care Act, a government health agency reported on Wednesday.

healthNews reuters.com

Home births in rural areas just as safe as in cities

(Reuters Health) - Home births may not be more dangerous for healthy rural mothers than for their urban counterparts, a recent U.S. study suggests.

healthNews reuters.com

Roche to seize leap-frog opportunity in lung cancer

LONDON (Reuters) - After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer.

healthNews reuters.com

Kids aren’t protecting themselves against STDs during oral sex

(Reuters Health) - Adolescents and young adults regularly engage in oral sex but seldom use condoms to prevent the spread of sexually transmitted diseases, new research shows.

healthNews reuters.com

FDA proposes drug development guidance for rare pediatric diseases

(Reuters) - The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher's disease, by eliminating the need for certain trials and minimizing patient enrollment.

healthNews reuters.com

Sign-ups pick up in week five of 2018 Obamacare open enrollment - U.S.

WASHINGTON (Reuters) - The number of people signing up for 2018 Obamacare plans picked up significantly during the fifth week of open enrollment, a U.S. government agency reported on Wednesday, but the number of people signed up for such plans appears to be falling short of last year's numbers with just over a week of enrollment left.

healthNews reuters.com

Myanmar's opium crop plummets, but no victory over Asia's narco-boom: U.N.

BANGKOK (Reuters) - A "dramatic" drop in opium cultivation in Myanmar underscored a regional boom in demand for illegal synthetic drugs such as methamphetamine, which many Asian countries are struggling to combat, a senior U.N. official said on Wednesday.

healthNews reuters.com

GSK, other drugmakers bet on post-Brexit UK science

LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.

healthNews reuters.com

Australian watchdog takes GlaxoSmithKline, Novartis units to court

(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

healthNews reuters.com

Consistently lower cancer survival rates for black patients in U.S.

(Reuters Health) - Whether it's colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show.

healthNews reuters.com

Brazil, U.S. identify molecule to help fight citrus greening disease

SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.

healthNews reuters.com

Paraguay Congress legalizes planting of medical marijuana

ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.

healthNews reuters.com

Eating almonds with chocolate may lower cholesterol

(Reuters Health) - Overweight and obese people who eat almonds and chocolate every day may have lower cholesterol than their counterparts who don’t consume these foods, a recent experiment suggests.

healthNews reuters.com

Hospital patients are safe with substitute doctors

(Reuters Health) - Hospital patients’ survival rates don’t suffer when fill-in doctors substitute for the regular staff physicians, a U.S. study suggests.

companyNews reuters.com

BRIEF-Omega Flex Agreed To New Amended Revolving Line Of Credit Note

* OMEGA FLEX - ON DEC 1, CO AGREED TO NEW AMENDED & RESTATED REVOLVING LINE OF CREDIT NOTE & THIRD AMENDMENT TO LOAN AGREEMENT WITH SANTANDER BANK N.A.

healthNews reuters.com

Women get mixed messages about sexuality after childbirth

(Reuters Health) - Women receive mixed messages about the ways giving birth may affect their sex lives, according to a new report.

healthNews reuters.com

FDA approves Novo Nordisk diabetes drug Ozempic

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated competitive battle with Eli Lilly & Co's Trulicity.

sportsNews reuters.com

WADA reinstates suspended Mexico laboratory

(Reuters) - Mexico’s suspended anti-doping laboratory has been reinstated after correcting non-conformities, the World Anti-Doping Agency (WADA) said on Tuesday.

healthNews reuters.com

Galectin slumps after NASH drug misses main goal of mid-stage trial

(Reuters) - Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a mid-stage trial, sending its shares plunging 48 percent on Tuesday.

healthNews reuters.com

Shire in deal to develop a new way to administer hemophilia drug

(Reuters) - Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.

healthNews reuters.com

Galectin says NASH drug misses main goal of midstage trial

(Reuters) - Galectin Therapeutics Inc said on Tuesday its experimental drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a midstage trial.

healthNews reuters.com

Philippines halts sale of dengue vaccine as Sanofi downplays risk

MANILA/LONDON (Reuters) - The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases.

healthNews reuters.com

WHO backs Philippines suspension of Sanofi's dengue vaccine

GENEVA (Reuters) - The World Health Organization supported a decision by the Philippines Department of Health on Tuesday to suspend vaccinations with Sanofi's dengue drug Dengvaxia, the WHO said in a statement.

companyNews reuters.com

Severe dengue vaccine risk in uninfected '2 in a 1,000' -Sanofi

LONDON, Dec 5 (Reuters) - French drugmaker Sanofi said on Tuesday the risk of severe dengue occurring in previously uninfected people given its Dengvaxia dengue vaccine was around two in 1,000 and these individuals recovered with treatment.

companyNews reuters.com

Trial results of Zika vaccine Sanofi dropped show promise

CHICAGO, Dec 4 (Reuters) - A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported on Monday.

cnn.com

Dengue vaccine found to worsen disease symptoms

The Philippines has suspended its large-scale dengue vaccination effort amid the surprising results of a new study conducted by the vaccine's manufacturer.

healthNews reuters.com

Court-mandated opioid rehab rarely meets medical standards

(Reuters Health) - Fewer than one in 20 people with opioid addiction problems who are ordered into rehab programs by the courts receive methadone or buprenorphine, two drugs doctors consider the best treatment option, a U.S. study suggests.

healthNews reuters.com

Montana sues OxyContin maker Purdue over opioid epidemic

(Reuters) - Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.

healthNews reuters.com

Trouble mounts for Sanofi dengue vaccine over safety concerns

(Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said it could actually worsen the disease in some cases.

companyNews reuters.com

WRAPUP 1-Trouble mounts for Sanofi dengue vaccine over safety concerns

Dec 4 (Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said it could actually worsen the disease in some cases.

healthNews reuters.com

Tattooed wish for withholding treatment not good enough, doctors say

(Reuters Health) - Consumers are often told, "Put it in writing." But in the case of a hospitalized Florida man facing death, displaying his wish by having it tattooed on his chest wasn't good enough.

healthNews reuters.com

Healthcare prices hard to find online

Reuters Health - Consumers who search online for prices of common medical procedures may be disappointed by what they find, a U.S. study suggests.

healthNews reuters.com

Sanofi says monitoring outcomes of ongoing dengue vaccination schemes

PARIS (Reuters) - Sanofi on Monday said it was monitoring outcomes of ongoing public programs involving its dengue vaccine, Dengvaxia, following the launch of a probe in the Philippines.

healthNews reuters.com

WHO reviewing data on Sanofi dengue vaccine, urges limited use

GENEVA (Reuters) - The World Health Organization (WHO) said on Monday it hoped to conduct a "full review" by year-end of data on Sanofi's dengue vaccine Dengvaxia.

healthNews reuters.com

Poor regulation, dodgy pills spur plan for African drugs agency

LONDON (Reuters) - Last July, Ugandan officials seized fake versions of the cancer drug Avastin on sale in Kampala, revealing only the tip of an iceberg of bogus medicines found all too often in Africa.

healthNews reuters.com

Brazil recommends restrictions on Sanofi dengue vaccine

BRASILIA (Reuters) - The Brazilian government said on Monday it has suggested restrictions on the use of a dengue vaccine that has been suspended elsewhere after French drug company Sanofi SA said it could worsen the disease in some cases.

healthNews reuters.com

Therapix expects to have results of Tourette's drug trial by end of first quarter

TEL AVIV (Reuters) - Israel's Therapix Biosciences said on Monday it expects by the end of March to have the results from its mid-stage trial of a cannabinoid-based drug for treating Tourette's syndrome which could be worth billions of dollars in revenues.

healthNews reuters.com

Hungary's Richter says no link seen between Esmya drug and liver damage

BUDAPEST (Reuters) - Hungarian drugmaker Richter's clinical data for its uterine fibroid treatment Esmya indicate no demonstrable link with liver damage, the firm said on Monday.

healthNews reuters.com

Denmark's Alk Abello suspends dividend to support North America investment

(Reuters) - Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns ($159 million) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.

businessNews reuters.com

Philippines orders probe into Sanofi dengue vaccine for 730,000 children

MANILA (Reuters) - The Philippines ordered a probe on Monday into the immunisation of more than 730,000 children with a vaccine for dengue that has been suspended following an announcement by French drug company Sanofi that it could worsen the disease in some cases.

healthNews reuters.com

Danish pharma company Alk Abello to invest 1 billion crowns in North America

(Reuters) - Danish pharma company Alk Abello said on Monday it would invest about 1 billion Danish crowns ($159.5 million) over the next three years to develop its North America business and said it expected earnings to be subdued during this period.

businessNews reuters.com

Philippines orders probe into vaccine, Sanofi says no deaths reported

MANILA (Reuters) - The Philippines ordered a probe on Monday into the immunization of more than 730,000 children with a dengue vaccine that has since been suspended, while French drug company Sanofi said no deaths had been reported as a result of the program.

cnn.com

Famed Met Opera conductor suspended amid sexual abuse allegations

New York's Metropolitan Opera suspended former music director James Levine on Sunday pending an internal investigation into multiple allegations of sexual misconduct against the famed conductor.

healthNews reuters.com

Sanofi says no reported deaths in Philippines related to dengue vaccine

MANILA (Reuters) - There have been no reported deaths in the Philippines related to a suspended dengue vaccine made by Sanofi, an official from the pharmaceutical company said on Monday.

healthNews reuters.com

Cholera could resurge in Yemen due to lack of aid, fuel: WHO

GENEVA (Reuters) - Another wave of cholera could strike Yemen, where a Saudi-led coalition blockade has cut off fuel for hospitals, water pumps and vital aid supplies for starving children, the World Health Organization (WHO) said on Sunday.

healthNews reuters.com

Philippine president vows to get to the bottom of dengue vaccine 'health scam'

MANILA (Reuters) - The office of the Philippine president on Sunday vowed to hold accountable those responsible for a suspended dengue immunization program, which it said placed thousands of lives at risk.

healthNews reuters.com

U.S. Senate tax bill accomplishes major Obamacare repeal goal

WASHINGTON (Reuters) - The sweeping tax overhaul that passed the U.S. Senate on Saturday contains the Republicans' biggest blow yet to former President Barack Obama's healthcare law, repealing the requirement that all Americans obtain health insurance.

healthNews reuters.com

First U.S. birth for woman with transplanted uterus occurs in Texas

(Reuters) - For the first time in the United States, a woman with a transplanted uterus gave birth, officials at a Dallas hospital said on Friday.

companyNews reuters.com

UPDATE 1-Sanofi ends development of C. difficile vaccine

Dec 1 (Reuters) - Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection, after an early look at late-stage trial results indicated a low probability for success.

healthNews reuters.com

Patients have different hospital outcomes when regular doctors see them

(Reuters Health) - Many outcomes for hospital patients – including how long they stay and their survival odds after they go home – may depend on whether they’re cared for by their primary care physician or another type of doctor, a U.S. study suggests.

healthNews reuters.com

FDA approves heart protection claims for Amgen cholesterol drug

(Reuters) - Amgen Inc can now promote the ability of its potent but expensive cholesterol drug to reduce the risk of heart attacks and strokes, after U.S. health regulators approved adding those benefits to the medicine's prescribing label, the company said on Friday.

Basketball nytimes.com

On Pro Basketball: The All-Star Who Ended Ugly Streaks for the Warriors and the Knicks

David Lee, 34, unexpectedly announced his retirement from the N.B.A. last month. He took a ring and some extraordinary memories with him.

healthNews reuters.com

Sanofi ends development of Clostridium difficile vaccine

(Reuters) - Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection, after an early look at late-stage trial results indicated a low probability for success.

companyNews reuters.com

Sanofi ends development of C. difficile vaccine

Dec 1 (Reuters) - Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection, after an early look at late-stage trial results indicated a low probability for success.

healthNews reuters.com

Fetuses grow differently in obese women

(Reuters Health) - Obese pregnant women who don’t have serious medical problems are still more likely to have unusually large babies than mothers who aren’t obese, a recent study suggests.

healthNews reuters.com

Nestle, Stada prepare rival bids for Germany's Merck consumer health: sources

LONDON/FRANKFURT (Reuters) - Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters.